Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced ...

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal ...

This understanding is driving a shift from isolated tests to comprehensive diagnostic panels; carefully structured groups of ...

Please provide your email address to receive an email when new articles are posted on . A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic ...